Omeros (OMER) Net Margin (2010 - 2026)
Omeros (OMER) posted Net Margin of 48.63% for Q1 2026, down 54.71% sequentially from 107.36% in Q2 2022.
Powered by 
Analysis
Omeros (OMER) Net Margin (2010 - 2026) Analysis & Trends
Omeros has reported Net Margin for 14 years, with the latest figure at 48.63% in Q1 2026.
- Quarterly Net Margin changed N/A year-over-year to 48.63% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.02% (up 4505.0% YoY) and the FY2020 annual result came in at 47.51%, down 873.0% from the prior year.
- Net Margin retreated to 48.63% in Q1 2026 per OMER's latest filing, from 107.36% in the prior quarter.
- Over five years, Net Margin peaked at 107.36% in Q2 2022 and troughed at 48.63% in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -3.12% |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn | 46.38% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.38% |
| Mar 31, 2026 | 566.66% |
| Jun 30, 2022 | -305.38% |
| Mar 31, 2022 | -471.86% |
| Dec 31, 2021 | -525.20% |
| Sep 30, 2021 | -3.76% |
| Jun 30, 2021 | -100.36% |
| Mar 31, 2021 | -168.60% |
| Dec 31, 2020 | -680.03% |
| Sep 30, 2020 | -147.29% |
| Jun 30, 2020 | -248.77% |
| Mar 31, 2020 | -125.67% |
| Dec 31, 2019 | -334.80% |
| Sep 30, 2019 | -55.14% |
| Jun 30, 2019 | -55.58% |
| Mar 31, 2019 | -114.05% |
| Dec 31, 2018 | -107.29% |
| Sep 30, 2018 | -869.01% |
| Jun 30, 2018 | -2,072.08% |
| Mar 31, 2018 | -1,921.54% |